Wednesday, 14 October 2026European Markets

TOUR EIFFEL, NEDAP, Another 2 Companies Have A High Estimated Dividend Yield

Loading stream...

(vianews) - tour eiffel (eiff.pa), nedap (nedap.as), nedap (nedap.as) have the highest dividend yield stocks on this list.

financial asset forward dividend yield updated (est)
tour eiffel (eiff.pa) 7.35% 2024-07-14 12:03:42
nedap (nedap.as) 5.08% 2024-07-19 08:03:10
nedap (nedap.as) 5.08% 2024-07-19 08:03:10
altamir (lta.pa) 3.91% 2024-07-19 08:45:31

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. tour eiffel (eiff.pa)

7.35% foward dividend yield

tour eiffel's last close was €8.98, 41.88% below its 52-week high of €15.45. intraday change was 9.05%.

with a property portfolio amounting to €1.7bn, société de la tour eiffel is an integrated property company with a strong culture of services. this agile company operates in various asset classes, including offices, urban logistics, managed residential and retail, in greater paris and other major french metropolitan areas. an active player throughout the property cycle, it assists its tenants - companies of all sizes and sectors - through high-standard direct management of its properties. société de la tour eiffel conducts a pro-active and transversal csr policy that is an integral part of its strategic orientations. société de la tour eiffel is listed on euronext paris (b board) - isin code: fr0000036816 - reuters: teif.pa - bloomberg: eiff.fp - member of the ieif foncières and ieif immobilier france indices.

earnings per share

as for profitability, tour eiffel has a trailing twelve months eps of €-0.65.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -6.88%.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, tour eiffel's stock is considered to be overbought (>=80).

dividend yield

as stated by morningstar, inc., the next dividend payment is on jun 13, 2023, the estimated forward annual dividend rate is 0.75 and the estimated forward annual dividend yield is 7.35%.

more news about tour eiffel.

2. nedap (nedap.as)

5.08% foward dividend yield

nedap's last close was €59.80, 12.83% under its 52-week high of €68.60. intraday change was 0.67%.

nedap n.v., together with its subsidiaries, develops and supplies technological solutions in the netherlands, germany, rest of europe, north america, and internationally. it offers software services, which allow healthcare institutions in planning, registering, and administering care; id cloud app, a rfid solutions for inventory management, simplified shop processes, and prevention of shrinkage; and technological solutions for individual animal monitoring and management for the dairy farming industry. the company also develops access control and security systems for companies and institutions. nedap n.v. was founded in 1929 and is headquartered in groenlo, the netherlands.

earnings per share

as for profitability, nedap has a trailing twelve months eps of €3.29.

pe ratio

nedap has a trailing twelve months price to earnings ratio of 18.3. meaning, the purchaser of the share is investing €18.3 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 25.89%.

more news about nedap.

3. nedap (nedap.as)

5.08% foward dividend yield

nedap's last close was €59.80, 12.83% below its 52-week high of €68.60. intraday change was 0.67%.

nedap n.v., together with its subsidiaries, develops and supplies technological solutions in the netherlands, germany, rest of europe, north america, and internationally. it offers software services, which allow healthcare institutions in planning, registering, and administering care; id cloud app, a rfid solutions for inventory management, simplified shop processes, and prevention of shrinkage; and technological solutions for individual animal monitoring and management for the dairy farming industry. the company also develops access control and security systems for companies and institutions. nedap n.v. was founded in 1929 and is headquartered in groenlo, the netherlands.

earnings per share

as for profitability, nedap has a trailing twelve months eps of €3.29.

pe ratio

nedap has a trailing twelve months price to earnings ratio of 18.3. meaning, the purchaser of the share is investing €18.3 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 25.89%.

dividend yield

as stated by morningstar, inc., the next dividend payment is on apr 15, 2024, the estimated forward annual dividend rate is 3.2 and the estimated forward annual dividend yield is 5.08%.

more news about nedap.

4. altamir (lta.pa)

3.91% foward dividend yield

altamir's last close was €25.80, 9.79% below its 52-week high of €28.60. intraday change was -1.16%.

pe ratio

altamir has a trailing twelve months price to earnings ratio of 33.12. meaning, the purchaser of the share is investing €33.12 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -2%.

yearly top and bottom value

altamir's stock is valued at €25.50 at 02:50 est, way below its 52-week high of €28.60 and way higher than its 52-week low of €22.44.

volume

today's last reported volume for altamir is 233 which is 87.03% below its average volume of 1797.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, altamir's stock is considered to be oversold (<=20).

more news about altamir.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com